The answer lies in balance
The FDA has identified serious adverse events associated with CJC-1295 and has raised concerns about immunogenicity, impurities, and limited clinical data
The possible effect of the long-term use of glucagon-like peptide-1 receptor agonists (GLP-1RA) on hba1c and lipid profile in type 2 diabetes mellitus: a retrospective study in Kauh, Jeddah, Saudi Arabia
It prevents arterial calcifications by binding calcium crystals and blocking bone morphogenetic protein-2 (BMP-2), a pro-mineralizing factor (136)
The post says an eGFR assessment is recommended before initiation, especially in older adults or people with diabetes, and it notes that both medications can influence fluid balance and renal perfusion
Brands Medical Authority Dr